Articles published by Organon & Co.
Organon Announces Quarterly Dividend
October 30, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
October 19, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
August 11, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
July 16, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
June 22, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
From Organon & Co.
Via Business Wire
Tickers
OGN
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon Cancels First Quarter Earnings Call
April 29, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Sun Pharma signs Definitive Agreement to Acquire Organon
April 26, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
February 23, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
February 12, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
January 29, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
Organon Completes Divestiture of JADA® System to Laborie
January 28, 2026
From Organon & Co.
Via Business Wire
Tickers
OGN
From Organon & Co.
Via Business Wire
Tickers
OGN